New combo trial aims to tame tough breast cancers
Disease control
Recruiting now
This study is testing if adding the drug tocilizumab to standard chemotherapy works better than chemotherapy alone for controlling metastatic triple-negative or estrogen-receptor-low breast cancer. It will enroll 168 Black and non-Black patients to see if the combination improves…
Phase: PHASE2 • Sponsor: Kathy Miller • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC